Patient Navigator Blog
Hi, and welcome to the Patient Navigation corner of the ARENA2 study website. We’re glad you found us online and we’re even happier to have you visit our page.
With backgrounds in social work, education, and psychology our Patient Navigation Team is equipped with the tools necessary to support you through the study. From educating you about the basics of clinical studies and ARENA2 to providing you with strategies to best handle the study activities and tests to checking in with you virtually every week to make sure everything is running smoothly in the trial.
We have navigators fluent in English, Spanish, and French to better serve your needs.
We will also work with your study coordinators and your physician at your study sites to ensure that you receive coordinated support.
Arilix, Danielle, and I are excited to get to know you all better and support you on this journey!
Needle Phobia: What it is, what it isn’t and how to help Research has shown that one of the biggest fears children have about visiting their pediatrician is a fear of needles (Kortesluoma & Nikkonen, 2004). For chronically ill children who undergo frequent procedures such as intravenous infusions (IVs), blood draws or steroid injections, repeated…
The Importance of Prep: Preparing Children and Teens for Medical Procedures There are few things more difficult for a parent or caregiver than watching a loved one in a heightened state of anxiety or worse, in pain. For many parents, this is a rare occurrence—perhaps a fall off a bike led to a broken arm…
dRTA Communities and Resources
Since its founding in 2007, Advicenne has been dedicated to developing and commercializing innovative treatments that address unmet medical needs in the area of nephroloy. Our lead drug candidate, ADV7103, is in late-stage clinical trials for primary distal renal tubular acidosis (dRTA). Listed on both the Euronext Paris and Euronext Brussels stock exchanges, the company is headquartered in Paris, France.
You are not alone. Connect with other members of the dRTA community on social media and with organizations providing education and support.
ADV7103 is an investigational product and has not been demonstrated to be safe and effective in the US population.